{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:07Z","timestamp":1792787887240,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":96,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Wuhan Natural Science Foundation Exploration Plan","award":["2024040801020374"],"award-info":[{"award-number":["2024040801020374"]}]},{"name":"Wuhan Natural Science Foundation Exploration Plan","award":["2025020701020268"],"award-info":[{"award-number":["2025020701020268"]}]},{"name":"Wuhan Municipal Health Commission Chenxing program","id":[{"id":"https:\/\/ror.org\/04jjn5s14","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wuhan 2023 Medical Research Project","award":["WX23Q17"],"award-info":[{"award-number":["WX23Q17"]}]},{"name":"Wuhan 2024 Talent Program"},{"name":"Hubei Natural Science Foundation","award":["2024AFB482"],"award-info":[{"award-number":["2024AFB482"]}]},{"name":"Hubei Natural Science Foundation","award":["2024AFB479"],"award-info":[{"award-number":["2024AFB479"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00869-x","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:54:53Z","timestamp":1783763693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-37a facilitates allergen immunotherapy in a house dust mite-induced mouse model of allergic asthma"],"prefix":"10.1186","volume":"27","author":[{"given":"Zheng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"6","key":"869_CR1","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jaci.2020.02.001","volume":"145","author":"K Niespodziana","year":"2020","unstructured":"Niespodziana K, Borochova K, Pazderova P, Schlederer T, Astafyeva N, Baranovskaya T, et al. Toward personalization of asthma treatment according to trigger factors. J Allergy Clin Immunol. 2020;145(6):1529\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"869_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1398-9995.2009.01967.x","volume":"64","author":"J Li","year":"2009","unstructured":"Li J, Sun B, Huang Y, Lin X, Zhao D, Tan G, et al. A multicentre study assessing the prevalence of sensitizations in patients with asthma and\/or rhinitis in China. Allergy. 2009;64(7):1083\u201392.","journal-title":"Allergy"},{"issue":"1","key":"869_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1465-9921-12-95","volume":"12","author":"J Li","year":"2011","unstructured":"Li J, Huang Y, Lin X, Zhao D, Tan G, Wu J, et al. Influence of degree of specific allergic sensitivity on severity of rhinitis and asthma in Chinese allergic patients. Respir Res. 2011;12(1):95.","journal-title":"Respir Res"},{"key":"869_CR4","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","volume":"85","author":"ZI Koml\u00f3si","year":"2022","unstructured":"Koml\u00f3si ZI, van de Veen W, Kov\u00e1cs N, Sz\u0171cs G, Sokolowska M, O\u2019Mahony L, et al. Cellular and molecular mechanisms of allergic asthma. Mol Aspects Med. 2022;85:100995.","journal-title":"Mol Aspects Med"},{"key":"869_CR5","doi-asserted-by":"publisher","first-page":"101334","DOI":"10.1016\/j.smim.2019.101334","volume":"46","author":"JC Virchow","year":"2019","unstructured":"Virchow JC. Allergen immunotherapy (AIT) in asthma. Semin Immunol. 2019;46:101334.","journal-title":"Semin Immunol"},{"issue":"2","key":"869_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1398-9995.2005.00913.x","volume":"61","author":"H Wang","year":"2006","unstructured":"Wang H, Lin X, Hao C, Zhang C, Sun B, Zheng J, et al. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy. 2006;61(2):191\u20137.","journal-title":"Allergy"},{"issue":"12","key":"869_CR7","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/all.14078","volume":"74","author":"MC van Zelm","year":"2019","unstructured":"van Zelm MC, McKenzie CI, Varese N, Rolland JM, O\u2019Hehir RE. Recent developments and highlights in immune monitoring of allergen immunotherapy. Allergy. 2019;74(12):2342\u201354.","journal-title":"Allergy"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"108115","DOI":"10.1016\/j.pharmthera.2022.108115","volume":"237","author":"L Hesse","year":"2022","unstructured":"Hesse L, Oude Elberink JNG, van Oosterhout AJM, Nawijn MC. Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future. Pharmacol Ther. 2022;237:108115.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"869_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jaip.2021.03.029","volume":"9","author":"MH Shamji","year":"2021","unstructured":"Shamji MH, Layhadi JA, Sharif H, Penagos M, Durham SR. Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens. J Allergy Clin Immunol Pract. 2021;9(5):1769\u201378.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"869_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0092-8674(86)90386-7","volume":"45","author":"I Kovesdi","year":"1986","unstructured":"Kovesdi I, Reichel R, Nevins JR. Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 1986;45(2):219\u201328.","journal-title":"Cell"},{"issue":"6","key":"869_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1586\/17476348.2015.1109452","volume":"9","author":"L Lunding","year":"2015","unstructured":"Lunding L, Schr\u00f6der A, Wegmann M. Allergic airway inflammation: unravelling the relationship between IL-37, IL-18R\u03b1 and Tir8\/SIGIRR. Expert Rev Respir Med. 2015;9(6):739\u201350.","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"869_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11(11):1014\u201322.","journal-title":"Nat Immunol"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"696605","DOI":"10.3389\/fimmu.2021.696605","volume":"12","author":"Z Su","year":"2021","unstructured":"Su Z, Tao X. Current Understanding of IL-37 in Human Health and Disease. Front Immunol. 2021;12:696605.","journal-title":"Front Immunol"},{"issue":"9","key":"869_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2174\/1389450121666200429114926","volume":"21","author":"J Bai","year":"2020","unstructured":"Bai J, Li Y, Li M, Tan S, Wu D. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases. Curr Drug Targets. 2020;21(9):855\u201363.","journal-title":"Curr Drug Targets"},{"key":"869_CR15","doi-asserted-by":"publisher","unstructured":"Ueno-Shuto K, Kamei S, Hayashi M, Fukuyama A, Uchida Y, Tokutomi N, et al. A splice switch in SIGIRR causes a defect of IL-37-dependent anti-inflammatory activity in cystic fibrosis airway epithelial cells. Int J Mol Sci. 2022;23(14):7748. https:\/\/doi.org\/10.3390\/ijms23147748.","DOI":"10.3390\/ijms23147748"},{"issue":"8","key":"869_CR16","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.4049\/jimmunol.1801515","volume":"203","author":"MS Kim","year":"2019","unstructured":"Kim MS, Baek AR, Lee JH, Jang AS, Kim DJ, Chin SS, et al. IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-\u03b21 Production in Mice. J Immunol. 2019;203(8):2265\u201375.","journal-title":"J Immunol"},{"key":"869_CR17","doi-asserted-by":"publisher","first-page":"113684","DOI":"10.1016\/j.biopha.2022.113684","volume":"155","author":"T Wu","year":"2022","unstructured":"Wu T, Xu K, Liu C, Li Y, Li M. Interleukin-37 ameliorates cigarette smoke-induced lung inflammation in mice. Biomed Pharmacother. 2022;155:113684.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"869_CR18","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41423-023-01091-0","volume":"20","author":"R Wei","year":"2023","unstructured":"Wei R, Han X, Li M, Ji Y, Zhang L, Christodoulou MI, et al. The nuclear cytokine IL-37a controls lethal cytokine storms primarily via IL-1R8-independent transcriptional upregulation of PPAR\u03b3. Cell Mol Immunol. 2023;20(12):1428\u201344.","journal-title":"Cell Mol Immunol"},{"key":"869_CR19","doi-asserted-by":"publisher","unstructured":"Cui L, Qin X, Fu T, Li C, Wang D, Hu Y, et al. Attenuated airways inflammation and remodeling in IL-37a and IL-37b transgenic mice with an ovalbumin-induced chronic asthma. Cell Immunol. 2023;391\u2013392:104759. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104759.","DOI":"10.1016\/j.cellimm.2023.104759"},{"issue":"4","key":"869_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/all.12566","volume":"70","author":"L Lunding","year":"2015","unstructured":"Lunding L, Webering S, Vock C, Schr\u00f6der A, Raedler D, Schaub B, et al. IL-37 requires IL-18R\u03b1 and SIGIRR\/IL-1R8 to diminish allergic airway inflammation in mice. Allergy. 2015;70(4):366\u201373.","journal-title":"Allergy"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"106017","DOI":"10.1016\/j.intimp.2019.106017","volume":"78","author":"M Guan","year":"2020","unstructured":"Guan M, Ma H, Fan X, Chen X, Miao M, Wu H. Dexamethasone alleviate allergic airway inflammation in mice by inhibiting the activation of NLRP3 inflammasome. Int Immunopharmacol. 2020;78:106017.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"869_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.resp.2011.12.008","volume":"181","author":"C Dong","year":"2012","unstructured":"Dong C, Wang G, Li B, Xiao K, Ma Z, Huang H, et al. Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. Respir Physiol Neurobiol. 2012;181(1):21\u20138.","journal-title":"Respir Physiol Neurobiol"},{"issue":"10","key":"869_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nri912","volume":"2","author":"RA Daynes","year":"2002","unstructured":"Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2(10):748\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"869_CR24","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/all.13395","volume":"73","author":"J Lv","year":"2018","unstructured":"Lv J, Xiong Y, Li W, Cui X, Cheng X, Leng Q, et al. IL-37 inhibits IL-4\/IL-13-induced CCL11 production and lung eosinophilia in murine allergic asthma. Allergy. 2018;73(8):1642\u201352.","journal-title":"Allergy"},{"issue":"10196","key":"869_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(19)31147-X","volume":"394","author":"K Huang","year":"2019","unstructured":"Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407\u201318.","journal-title":"Lancet"},{"issue":"42","key":"869_CR26","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.1416714111","volume":"111","author":"Y Luo","year":"2014","unstructured":"Luo Y, Cai X, Liu S, Wang S, Nold-Petry CA, Nold MF, et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A. 2014;111(42):15178\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"869_CR27","doi-asserted-by":"publisher","first-page":"14478","DOI":"10.1038\/srep14478","volume":"5","author":"X Shuai","year":"2015","unstructured":"Shuai X, Wei-min L, Tong YL, Dong N, Sheng ZY, Yao YM. Expression of IL-37 contributes to the immunosuppressive property of human CD4\u2009+\u2009CD25+ regulatory T cells. Sci Rep. 2015;5:14478.","journal-title":"Sci Rep"},{"issue":"3","key":"869_CR28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/all.15072","volume":"77","author":"A Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der A, Lunding LP, Zissler UM, Vock C, Webering S, Ehlers JC, et al. IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33. Allergy. 2022;77(3):856\u201369.","journal-title":"Allergy"},{"issue":"17","key":"869_CR29","doi-asserted-by":"publisher","first-page":"21729","DOI":"10.18632\/aging.203515","volume":"13","author":"S Gao","year":"2021","unstructured":"Gao S, Wang J, Zhang Q, Shu J, Li C, Li H, et al. Cytokine antibody array-based analysis of IL-37 treatment effects in asthma. Aging. 2021;13(17):21729\u201342.","journal-title":"Aging"},{"issue":"5","key":"869_CR30","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.24996\/ijs.2024.65.5.6","volume":"65","author":"AA Kadhem","year":"2024","unstructured":"Kadhem AA. The Role of IL-37 in allergic Rhinitis, Asthma and Urticaria Diseases in Samples of Iraqi patients. Iraqi J Sci. 2024;65(5):2418\u201330.","journal-title":"Iraqi J Sci"},{"issue":"6","key":"869_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.reval.2021.07.004","volume":"61","author":"MB Ahmed","year":"2021","unstructured":"Ahmed MB, Ad\u2019hiah AH. Reduced levels of interleukin-37 in serum of patients with allergic rhinitis or asthma. Revue Fran\u00e7aise d\u2019Allergologie. 2021;61(6):410\u20134.","journal-title":"Revue Fran\u00e7aise d\u2019Allergologie"},{"issue":"1","key":"869_CR32","first-page":"43","volume":"63","author":"CA Jakwerth","year":"2025","unstructured":"Jakwerth CA, Zissler UM, Oelsner M, Pechtold L, Zur Bonsen L, Plaschke M, et al. Nasal secretions trace epithelial type 2 response to allergen-specific immunotherapy. Rhinology. 2025;63(1):43\u201353.","journal-title":"Rhinology"},{"key":"869_CR33","doi-asserted-by":"publisher","first-page":"103415","DOI":"10.1016\/j.jaut.2025.103415","volume":"153","author":"L Wang","year":"2025","unstructured":"Wang L, Christodoulou MI, Jin Z, Ma Y, Hossen M, Ji Y, et al. Human regulatory B cells suppress autoimmune disease primarily via interleukin-37. J Autoimmun. 2025;153:103415.","journal-title":"J Autoimmun"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00869-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:19:49Z","timestamp":1792066789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00869-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00869-x","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments and methods were performed in accordance with the relevant guidelines and regulations, and all experimental protocols, including animal experimental designs and procedures, were reviewed and approved by the Institutional Ethics Committee and the Animal Welfare Committee of Wuhan Fourth Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}